Our portfolio offers the right molecular genetic test for every stage of patient management – from initial diagnosis and therapy guidance to follow-up care. Join this webinar to learn how our tumor diagnostics can support you in selecting targeted therapies, monitoring disease progression, and detecting relapses early. Our comprehensive analyses combine medical expertise with the latest scientific insights to provide clinically relevant results. Discover how you can effectively integrate our broad portfolio into your daily practice.
Our Speaker
Gözdenur Schmelzer
Product Management, Germline & Tumor Diagnostics
What We Cover in This Webinar
Learn how our genetic tumor diagnostics supports you in every phase of patient care.
Step 1: genetic tumor diagnostics
CancerPrecision® – molecular tumor profiling
CancerFusionRx® – RNA-based structural variants add-on
Step 2: disease monitoring
CancerDetect® – variant-specific monitoring
Step 3: long term monitoring of tumor burden
CancerMRD – minimal residual disease monitoring